Related

SDGs and Paris Agreement force to change the current society to a sustainable, circular and wellness society, as well as the bio-based society across the globe. Based on these circumstances, the Japanese government has developed the “Japan Bioeconomy Strategy” since 2019 to achieve the world’s most advanced bioeconomy society in Japan by 2030. 


The strategy has three featuring points:

  • to promote each market segment in the nine fields with bio-manufacturing, primary production, and healthcare, to achieve 92T yen market size by 2030
  • to create outstanding bio-communities by the end of FY2021 and attract human resources and investment, and enable new products and services
  • to draw up guidelines for data linkage and usage by the end of FY2022, and establish R&D and market introduction platform. 

Industry, academia, and local governments pursue together the strategy and are able to receive various supports from the related Japanese government ministries as needed. The strategy also points out that even if each company or university individually struggles with biological technologies, the real industrialization is unable to be accomplished, and that bio-communities with strong/unique sciences and technologies are absolutely essential in Japan for effective open innovation.

Furthermore, international collaboration is essential to promote bioeconomy, and there is high potential for creating synergies among states sharing fundamental values. Currently, six bio-communities, two global bio-communities and four local bio-communities with unique sciences and technologies, were certified by the Japanese Government Cabinet Office. Companies based in the EU are also invited to get involved and contribute.

Nine market-segments

  1. High functional biomaterials (lightweight properties, durability, safety)
  2.  Bioplastics (alternative general-purpose plastics)
  3. Sustainable primary industry system
  4. Organic (Biological) treatment of wastes and effluent
  5. Healthcare field (lifestyle improvement, functional foods, digital health)
  6. Biologics (e.g. antibodies, regenerative medicines, cell therapy, gene therapy, gene editing)
  7. Biological production system (production applying biological functions)
  8. Analysis, measurement, and experiment systems for biological products
  9. Large timber architecture / Smart forestry

 

Published: April 2023

EU-Japan Centre's News

More
The Centre quarterly newsletter, June 2026 issue, is now available. In this issue:   Last chance…
The Belgian-Luxembourg Chamber of Commerce in Japan (BLCCJ) is organizing the 13th edition of the…
Call for Applications: WCM October 2026 – 56th edition Applications are now open for the 56th…
The EU Japan Centre is releasing a weekly press review covering Japan's economic and business…
Last call for applications: Biotech Business Mission to Japan 2026 The EU-Japan Centre is…
Last call for applications: Digital Solutions Business Mission in Japan 2026 The EU-Japan Centre…

Events

More
Japan
16/03/2026 - 19/03/2026
  The next mission will take place from 23-26 March, 2027 Planned application period: September - early November 2026   Please note that this page is still under construction; content relating to…
Japan
05/10/2026 - 09/10/2026
Mission dates: 05 - 09 Oct 2026 Are you active in the biotech, pharma, or related healthcare sectors and seeking business, technology, or collaboration opportunities in Japan? This autumn, the EU-…
Time in Brussels
-
Time in Tokyo
-
Exchange rate
1€ = 185,364 JPY